Leading life sciences investors ARCH Venture Partners, F-Prime Capital, and Primer Ventures fuel company’s expansion into cell and gene therapy, oncology, and molecular diagnostics PALO ALTO, Calif.– Countable Labs, the developer of Countable PCR, a breakthrough single-molecule PCR technology redefining how science measures biology, today announced the closing of an oversubscribed $26 million financing round […]
Round co-led by NfX and Future Ventures will accelerate the build-out of deSIPHR, the nanophotonic chip platform mining the functional layer of biology at scale. PALO ALTO, CA — Pumpkinseed, The Biology Mining Company, today announced a $20 million Series A funding round to scale its protein sequencing platform, mining biological functional data at a resolution […]
ArgusEye, a provider of advanced sensor solutions for real-time monitoring and control of bioprocesses, today announced the closing of a €3.3M funding round. The round includes continued support from existing investors, Voima Ventures and Eir Ventures, along with new investor Impilo Partners Invest. The funding will accelerate the continued development of ArgusEye’s Auga™ platform, a […]
ESPOO, Finland — New Finnish deep-tech company aims to make ultra-early disease detection possible through single-molecule protein amplification, enabling the identification of molecular warning signals long before disease becomes clinically visible. The technology has the potential to shift healthcare from reactive treatment to true prevention, extend healthy lifespans, and reduce the global burden of cancer, neurological disorders, and […]
Fremont, Calif. – Alamar Biosciences, Inc. (“Alamar”), a leader in precision proteomics dedicated to advancing the early detection of disease, today announced the pricing of its upsized initial public offering of 11,250,000 shares of its common stock at a public offering price of $17.00 per share. In addition, Alamar has granted the underwriters a 30-day option […]
Recently, Geneus Technologies, a leading domestic company in nanopore sequencing technology, announced the completion of a nearly RMB 100 million B++ round of financing. This round of funding was led by CDBT Group, with participation from Si Chuan Venture Capital. The raised capital will be used to accelerate the commercialization of the world’s first “Single-base […]
Lightcast Raises $27 Million and Adds Industry Veteran to Accelerate Commercialization of Envisia ™Platform · Proceeds will help enhance workflows and expand single-cell functional assay portfolio · Brad Crutchfield joins as advisor to support early access growth and global launch CAMBRIDGE, England – Lightcast, a pioneering life science tools company focused on functional single-cell analysis, today announced […]
CAMBRIDGE, Mass. and SAN FRANCISCO, Calif. – Kytopen Corp., a leader in non-viral, continuous flow cellular engineering, today announced a Series B financing led by Telegraph Hill Partners, with participation from existing investors. The funding will accelerate Kytopen’s global commercial expansion and drive further adoption of its Flowfect® technology platform across the U.S. and Europe. […]
Funding supports expansion of manufacturing and commercial capacity for SemaCyte microcarrier platform Cambridge, UK: Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening needs, today announced it has raised $3.8 million USD (£2.9 million GBP). The fundraise was led by Parkwalk, and […]
Appoints Frederik Decouttere as CEO LAUSANNE, Switzerland — Alithea Genomics, an emerging leader in the field of large-scale RNA sequencing and transcriptomics, announced today the closing of its seed financing round with an additional CHF 3 million ($3.9 million), led by Genku Ventures and joined by Novalis Biotech and Zürcher Kantonalbank as well as several […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
